Only a handful of seats left for our "Welcome to the R&D Revolution" executive breakfast, and you can register here. The event is on Tuesday, 4/23 from 7:00 a.m. to 8:30 a.m., located conveniently next to the convention at Hyatt Regency McCormick Place.
John Carroll is moderating the panel featuring Briggs Morrison, EVP, Global Medicines Development, AstraZeneca ($AZN); Martin Fitchet, chief operating officer and heart disease expert for the global Johnson & Johnson ($JNJ) Pharmaceutical Research & Development organization; José-Carlos Gutiérrez-Ramos, SVP, head of BioTherapeutics R&D, Pfizer ($PFE); and Perry Nisen, SVP of Science and Innovation, GlaxoSmithKline ($GSK).
Ryan McBride hosts a panel, "Partnering in the Cloud - Can Pharma Drive Innovation through Big Data?" from 2:00 p.m. to 3:30 p.m on Tuesday at the What's Your BIO Theatre on the show floor. Find more info here.
Ryan will be talking to Marc Berger, Vice President, Real World Data and Analytics; Gunaretnam Rajagopal VP & CIO, Research, Bioinformatics & External Innovation at Janssen Pharmaceutical; Yury Rozenman, head of marketing at Global Commerce, British Telecom Services; and Kenneth E. Russell, Ph.D., Director, Advanced Services & Strategic Initiatives at CISCO.
Right after Ryan's panel, have a drink on us and meet the team at the FierceBiotech IT meetup from 3:30 p.m. to 4:00 p.m., in the Bio-IT Zone on the show floor.
And on Monday, 4/22 from 4:00 p.m. to 6:30 p.m., we'll be at Women In Bio's annual celebration featuring a keynote address by Jill Milne, CEO of Catabasis Pharmaceuticals. Register here for the event.
I'll also be there to kick things off with a short presentation on FierceBiotech's annual "Women in Biotech" report, highlighting the women we've featured previously. A few of them will be at the event, including Deborah Dunsire, CEO of Millennium Pharmaceuticals; Deborah Keller, EVP and Group President, R&D laboratories at Covance; Maxine Gowen, President and CEO of Trevena; Susan Molineaux, President and CEO of Calithera Biosciences; and Andrea Pfeifer, CEO of AC Immune.
-- Jennifer Levin (email | Twitter)